No Data
No Data
GuiZhouYongJi Printing Co.,Ltd's (SHSE:603058) On An Uptrend But Financial Prospects Look Pretty Weak: Is The Stock Overpriced?
GuiZhouYongJi PrintingLtd's (SHSE:603058) stock is up by a considerable 30% over the past three months. However, in this article, we decided to focus on its weak fundamentals, as long-term financial
Yongji Co., Ltd. (603058.SH) 2023 equity distribution: 0.8 yuan for every 10 shares, shares registered on May 31
Yongji Co., Ltd. (603058.SH) issued the 2023 equity distribution implementation notice. The company plans to implement profits...
Yongji Co., Ltd. (603058.SH): Australian subsidiary TB's products are currently in short supply
Gelonghui, May 17丨Yongji Co., Ltd. (603058.SH) said on the investor interactive platform that 1. The company will determine profit distribution policies scientifically, prudently, and reasonably based on factors such as its own business development plans, actual operating conditions, investor returns and related rules and requirements. 2. The products of the company's Australian subsidiary TB are currently in short supply. The two new nurseries are expected to be put into operation in June 2024, with an estimated production capacity of 1,400 kg, which can further reduce the insufficient production capacity for indoor planting. In 2024, outdoor dried flower production capacity is expected to increase to 1,000-1,500 kg, and
Yongji Co., Ltd. (603058.SH): As of April 30, 2024, the number of shareholders of the company was 15,410
Gelonghui, May 8, 丨 Yongji Co., Ltd. (603058.SH) said on the investor interactive platform that as of April 30, 2024, the number of shareholders of the company was 15,410.
Concerns Surrounding GuiZhouYongJi PrintingLtd's (SHSE:603058) Performance
GuiZhouYongJi Printing Co.,Ltd (SHSE:603058) just released a solid earnings report, and the stock displayed some strength. Despite this, our analysis suggests that there are some factors weakening th
Yongji Co., Ltd. (603058.SH): Currently, TB's medical marijuana business is mainly aimed at the Australian market
Gelonghui, April 10 | Yongji Co., Ltd. (603058.SH) said on the investor interactive platform that the company's Australian subsidiary TB's medical marijuana business revenue growth in the first quarter of 2024 was mainly due to increased market demand and the release of production capacity after the new greenhouse was put into operation. TB's two new greenhouses are expected to be put into operation in June 2024, with an estimated production capacity of 1,400 kg, which can further reduce the insufficient production capacity for indoor growing. In 2024, outdoor dried flower production capacity is expected to increase to around 1,000 kg, which can also effectively supplement the reduction of production capacity bottlenecks. Currently, TB's medical marijuana business is mainly aimed at mainland Australia
No Data